Abstract: To evaluate the implementation effect of traditional Chinese medicine (TCM) efficacy value payment policy in Liuzhou City in the context of health insurance DRG/DIP payment method reform. Through t-test, chi-square test and other statistical methods, mixed hemorrhoids were selected as the sample disease to evaluate the policy implementation effect of TCM efficacy value payment. The results show that compared with the western medicine DRG payment control group, the traditional Chinese medicine efficacy value payment group has shorter hospitalization days, lower medical expenses, and less medical insurance fund expenditures, which motivates the work enthusiasm of departments and doctors of traditional Chinese medicine hospitals and promote the integrity, inheritance and innovation of traditional Chinese medicine under the reform of medical methods. However, there are also problems such as too strict admission standards for some diseases and low medical insurance payment coefficients. Therefore, it is recommended to take the following measures to improve corresponding policies: optimize and strengthen clinical path management; expand the coverage of dominant TCM diseases; improve the medical quality evaluation system; implement incentives for doctors and departments to promote the realization of value-based medical insurance.